These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 18219807)
1. Global Advisory Committee on Vaccine Safety, 12-13 December 2007. Wkly Epidemiol Rec; 2008 Jan; 83(4):37-44. PubMed ID: 18219807 [No Abstract] [Full Text] [Related]
2. Global Advisory Committee on Vaccine Safety,12–13 June 2013. Wkly Epidemiol Rec; 2013 Jul; 88(29):301-12. PubMed ID: 23909011 [No Abstract] [Full Text] [Related]
3. Global Advisory Committee on Vaccine Safety, 1-2 December 2005. Wkly Epidemiol Rec; 2006 Jan; 81(2):15-9. PubMed ID: 16671243 [No Abstract] [Full Text] [Related]
4. Global Advisory Committee on Vaccine Safety, 29-30 November 2006. Wkly Epidemiol Rec; 2007 Jan; 82(3):18-24. PubMed ID: 17236262 [No Abstract] [Full Text] [Related]
5. Meeting of the Global Advisory Committee on Vaccine Safety, December 2010. Wkly Epidemiol Rec; 2011 Jan; 86(5):38-43. PubMed ID: 21299033 [No Abstract] [Full Text] [Related]
6. Global Advisory Committee on Vaccine Safety, 11–12 December 2013. Wkly Epidemiol Rec; 2014 Feb; 89(7):53-60. PubMed ID: 24707510 [No Abstract] [Full Text] [Related]
7. Global Advisory Committee on Vaccine Safety, 12-13 June 2007. Wkly Epidemiol Rec; 2007 Jul; 82(28-29):252-9. PubMed ID: 17642098 [No Abstract] [Full Text] [Related]
8. Global Advisory Committee on Vaccine Safety, December 2012. Wkly Epidemiol Rec; 2013 Feb; 88(6):65-72. PubMed ID: 23424731 [No Abstract] [Full Text] [Related]
9. Global Advisory Committee on Vaccine Safety,3-4 December 2009. Wkly Epidemiol Rec; 2010 Jan; 85(5):29-33. PubMed ID: 20151491 [No Abstract] [Full Text] [Related]
10. Global Advisory Committee on Vaccine Safety, December 2011. Wkly Epidemiol Rec; 2012 Feb; 87(6):53-9. PubMed ID: 22355832 [No Abstract] [Full Text] [Related]
11. Meningococcal B Vaccination (4CMenB) in Infants and Toddlers. Esposito S; Tagliabue C; Bosis S J Immunol Res; 2015; 2015():402381. PubMed ID: 26351647 [TBL] [Abstract][Full Text] [Related]
12. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Esposito S; Castellazzi L; Bosco A; Musio A; Stoddard J Immunotherapy; 2014; 6(4):395-408. PubMed ID: 24815780 [TBL] [Abstract][Full Text] [Related]
13. Global Advisory Committee on Vaccine Safety, 2-3 December 2004. Wkly Epidemiol Rec; 2005 Jan; 80(1):3-7. PubMed ID: 15673064 [No Abstract] [Full Text] [Related]
14. Neisseria meningitidis B vaccines: recent advances and possible immunization policies. Gasparini R; Amicizia D; Domnich A; Lai PL; Panatto D Expert Rev Vaccines; 2014 Mar; 13(3):345-64. PubMed ID: 24476428 [TBL] [Abstract][Full Text] [Related]
15. Neisseria meningitidis B vaccines. Panatto D; Amicizia D; Lai PL; Gasparini R Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622 [TBL] [Abstract][Full Text] [Related]
16. The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease. Zlotnick GW; Jones TR; Liberator P; Hao L; Harris S; McNeil LK; Zhu D; Perez J; Eiden J; Jansen KU; Anderson AS Hum Vaccin Immunother; 2015; 11(1):5-13. PubMed ID: 25483509 [TBL] [Abstract][Full Text] [Related]
17. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects. Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903 [TBL] [Abstract][Full Text] [Related]